Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;7(Suppl 8):S281.
doi: 10.21037/atm.2019.11.107.

PD-1 inhibition: a novel approach to the treatment of progressive multifocal leukoencephalopathy

Joseph R Berger  1
Affiliations
Editorial

PD-1 inhibition: a novel approach to the treatment of progressive multifocal leukoencephalopathy

Joseph R Berger. Ann Transl Med. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Joseph R. Berger has been a consultant for Amgen, Biogen, Celgene, Genentech/Roche, Merck/Serono, Millennium/Takeda, Novartis, and Shire. He serves on the scientific advisory boards of Excision-Bio and Inhibikase. He has received grant support from Biogen and Genentech/Roche.

Comment on

References

    1. Astrom KE, Mancall EL, Richardson EP., Jr Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958;81:93-111. - PubMed
    1. Berger JR. Progressive multifocal leukoencephalopathy. Handb Clin Neurol 2014;123:357-76. 10.1016/B978-0-444-53488-0.00017-1 - DOI - PubMed
    1. Kartau M, Verkkoniemi-Ahola A, Paetau A, et al. The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based Study. Open Forum Infect Dis 2019;6:ofz024. 10.1093/ofid/ofz024 - DOI - PMC - PubMed
    1. Anand P, Hotan GC, Vogel A, et al. Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study. Neurol Neuroimmunol Neuroinflamm 2019. doi: .10.1212/NXI.0000000000000618 - DOI - PMC - PubMed
    1. Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. Aids 1998;12:1149-54. 10.1097/00002030-199810000-00006 - DOI - PubMed